LSLaura Schlicksupp

Laura Schlicksupp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Schlicksupp has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Ingeborg Dreher

    AbbVie Deutschland GmbH & Co. KG, Knollstrasse 50, 67061 Ludwigshafen, Germany

    1 shared publication
  • Mario Richter

    Quantitative, Translational and ADME Sciences, AbbVie Deutschland GmbH & Co. KG, Knollstrasse, 67061 Ludwigshafen, Germany

    1 shared publication
  • Marta Boysen

    AbbVie Deutschland GmbH & Co. KG, Knollstrasse 50, 67061 Ludwigshafen, Germany

    1 shared publication
  • Ralf Loebbert

    AbbVie Deutschland GmbH & Co. KG, Knollstrasse 50, 67061 Ludwigshafen, Germany

    1 shared publication

Latest Publications

  • Open Access

    SEC Based Method for Size Determination of Immune Complexes of Therapeutic Antibodies in Animal Matrix

    by Marta Boysen, Laura Schlicksupp, Ingeborg Dreher, Ralf Loebbert, Mario Richter

    Therapeutic monoclonal antibodies (mAbs) represent a milestone in pharmacological development. Their superiority is based on the combination of high specificity, low toxicity, and long half-life that characterizes biologics. If biologics have Achilles’ heel, it is their potential immunogenicity. To better understand the impact of the size of immune complexes of mAbs on anti-drug antibody (ADA) dependent adverse reactions inMacaca fascicularis, we developed an efficient high-throughput size exclusion chromatography- (SEC-) based methodology that enables analysis of the size, size distribution, and ratio of free and ADA-complexed mAb in serum allowing for assessment of formation and clearance of circulating ADA-mAb immune complexes (CIC).